Lathosterol
Suppliers
Names
[ CAS No. ]:
80-99-9
[ Name ]:
Lathosterol
[Synonym ]:
Cholest-7-en-3beta-ol
Cholest-7-en-3-ol
5alpha-Cholest-7-en-3beta-ol
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
5alpha-cholest-7-en-3beta-ol
7-cholestenol
Lathosterol
Chemical & Physical Properties
[ Density]:
0.98 g/cm3
[ Boiling Point ]:
479.4ºC
[ Molecular Formula ]:
C27H46O
[ Molecular Weight ]:
386.65400
[ Flash Point ]:
208.9ºC
[ Exact Mass ]:
386.35500
[ PSA ]:
20.23000
[ LogP ]:
7.38870
[ Index of Refraction ]:
1.525
[ Storage condition ]:
2-8℃
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- FZ7000000
- CHEMICAL NAME :
- 5-alpha-Cholest-7-en-3-beta-ol
- CAS REGISTRY NUMBER :
- 80-99-9
- LAST UPDATED :
- 199709
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C27-H46-O
- MOLECULAR WEIGHT :
- 386.73
- WISWESSER LINE NOTATION :
- L E5 B666 IUTJ A1 E1 FY1&3Y1&1 OQ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 750 mg/kg/9W-I
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Tumorigenic - tumors at site of application
- REFERENCE :
- JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8. Volume(issue)/page/year: 19,977,1957
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
FZ7000000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 879(32) , 3806-11, (2011)
Phytosterols (PS; β-sitosterol and campesterol) and cholesterol precursors (CP; desmosterol and lathosterol) have been suggested as important biochemical markers of cholesterol intestinal absorption a...
J. Nutr. 144(8) , 1219-26, (2014)
The effect of weight loss on lipids differs among individuals, although whether it can modify the management of hereditary hyperlipidemias has not yet been explored. The objective of this study was to...
Atherosclerosis 225(2) , 388-96, (2012)
Objective Statins inhibit cholesterol synthesis but can upregulate cholesterol absorption, with higher doses producing larger effects. Ezetimibe inhibits cholesterol absorption but also upregulates sy...